cyclosporine has been researched along with Strongyloidiasis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malpica, L; Moll, S | 1 |
| Alexender, G; Ghoshal, U; Ghoshal, UC; Krishnani, N; Tripathi, S | 1 |
| Armson, A; Cunningham, GA; Grubb, WB; Mendis, AH | 1 |
| Palau, LA; Pankey, GA | 1 |
1 review(s) available for cyclosporine and Strongyloidiasis
| Article | Year |
|---|---|
Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases.
Topics: Adrenal Cortex Hormones; Aged; Antimetabolites; Cyclophosphamide; Cyclosporine; Female; Hematologic Diseases; Herpes Zoster; Humans; Immunosuppressive Agents; Infection Control; Infections; Pneumonia, Pneumocystis; Strongyloidiasis | 2020 |
3 other study(ies) available for cyclosporine and Strongyloidiasis
| Article | Year |
|---|---|
Strongyloides stercoralis infestation in a patient with severe ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Early Diagnosis; Humans; Hydrocortisone; Immunosuppressive Agents; Male; Prednisolone; Strongyloides stercoralis; Strongyloidiasis; Tropical Medicine | 2006 |
Murine strongyloidiasis: the effects of cyclosporin A and thiabendazole administered singly and in combination.
Topics: Administration, Oral; Animals; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Injections, Subcutaneous; Rats; Rats, Sprague-Dawley; Strongyloides ratti; Strongyloidiasis; Thiabendazole | 1995 |
Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant.
Topics: Animals; Antinematodal Agents; Cyclosporine; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Strongyloides stercoralis; Strongyloidiasis; Superinfection; Thiabendazole | 1997 |